Related Experiment Videos
Bioactive molecules and the future of pulp therapy.
Michel Goldberg1, Ngampis Six, Frank Decup
1Faculté de Chirurgie Dentaire, Université Paris V, Montrouge, France. mgoldod@aol.com
American Journal of Dentistry
|May 15, 2003
Summary
Bioactive molecules like Bone Sialoprotein (BSP) and Amelogenin Gene Splice Products can stimulate reparative dentin and pulp mineralization, offering new dental therapeutic tools.
Area of Science:
- Biomaterials science
- Regenerative dentistry
- Dental pulp biology
Background:
- Direct capping or pulp implantation of bioactive molecules can induce reparative dentin and pulp mineralization.
- Understanding the biological mechanisms of these therapies is crucial for dental applications.
Purpose of the Study:
- To review the biological mechanisms of bioactive molecule therapies for pulp repair and mineralization.
- To report experimental findings on Bone Sialoprotein (BSP)/collagen pellets and Specific Amelogenin Gene Splice Products in rat molars.
Main Methods:
- Experimental implantation of BSP/collagen pellets and Amelogenin Gene Splice Products adsorbed on agarose beads in rat maxillary molars.
- Comparison of experimental results with Bone Morphogenetic Protein-7 (BMP-7) and Calcium Hydroxide (Ca(OH)2).
Main Results:
- Varying molecular treatments resulted in distinct outcomes: dentin bridge formation, coronal pulp filling, or complete root canal mineralization.
- BSP/collagen and Amelogenin Gene Splice Products demonstrated specific mineralization and dentin repair capabilities.
Conclusions:
- Bioactive molecules like BSP and Amelogenin Gene Splice Products show promise for inducing reparative dentin and pulp mineralization.
- These molecules represent potential novel therapeutic agents for future dental treatments, offering alternatives to traditional methods.